Top Markets
Coin of the day
Nordhealth AS Nordhealth AS

Nordhealth AS

NORDH
Classement en actions #18301
Nordhealth AS provides healthcare software solutions in Norway, Finland,... Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychotherapists; EasyPractice, a PMS for therapists; and various PMS for veterinarians under the Vetserve, Sanimalis, Vetvision, and Vetera names. The company’s products comprise Nordhealth Connect, a communication platform for patients and healthcare professionals; and Navisec, a digital learning environment for training and orientation. In addition, it offers services related to implementation of the SaaS systems, such as consultancy services, education, and data conversion. Further, the company provides nordhealth.fi, a consumer booking portal. Nordhealth AS was founded in 2001 and is based in Oslo, Norway.
Prix de l'action
$2.60
Dernière synchronisation: 2026-09-02
Capitalisation boursière
$204.87M
Changement (1 jour)
5.08%
Changement (1 an)
-26.70%
Pays
NO
Échange Nordhealth AS (NORDH)

Catégorie

Bénéfices pour Nordhealth AS (NORDH)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Nordhealth AS, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Nordhealth AS de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$2.04B -
US
$266.26M -
AU
$295.53M -
US
$-259.89M -
US
- -
US